Advertisement

Health Insurance and the Financial Impact of IDDM in Families With a Child With IDDM

  1. Thomas J Songer, PHD,
  2. Ronald E LaPorte, PHD,
  3. Judith R Lave, PHD,
  4. Janice S Dorman, PHD and
  5. Dorothy J Becker, MBBCH, FCP(PAED)
  1. Department of Epidemiology, Department of Pediatrics, School of Medicine, University of Pittsburgh and the Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania
  2. Department of Health Services Administration, Department of Pediatrics, School of Medicine, University of Pittsburgh and the Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania
  3. Graduate School of Public Health, University of Pittsburgh and the Division of Endocrinology and Metabolism Department of Pediatrics, School of Medicine, University of Pittsburgh and the Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania
  1. Address correspondence and reprint requests to Thomas J. Songer, PhD, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261. E-mail: tjs{at}vms.cis.pitt.edu

Abstract

OBJECTIVE To examine the health insurance experience and out-of-pocket health care costs of families with a child with IDDM.

RESEARCH DESIGN AND METHODS A case-control study of 197 families with a child with IDDM and 142 control families with no diabetic children was conducted. IDDM-affected families were identified from the Allegheny County IDDM Registry. Brothers and sisters of the parents in the IDDM-affected families were asked to participate as control subjects. Health insurance coverage and the money that families spent on health care services and supplies not reimbursed by insurance (out-of-pocket costs) were assessed by questionnaire.

RESULTS No difference was found between the IDDM-affected and control families in the percentages with or without insurance. Families with low household incomes ($10,000–$19,999) were at the greatest risk for having no insurance. While coverage provided by private plans was similar between the IDDM-affected and control families, many families had no reimbursement for insulin (10%), syringes (10%), or blood testing strips (30%). Out-of-pocket expenses were 56% higher in the IDDM-affected families than in the control families. Seventeen percent of the IDDM-affected families had expenses over 10% of their household income. This particularly affected families with low household incomes. Pre-existing illness clauses and insurance denial affected only a small proportion of the case families.

CONCLUSIONS These data illustrate that most families with a child with IDDM have health insurance, yet still incur larger out-of-pocket health care costs than do families without the presence of diabetes. IDDM-affected families likely face a number of economic decisions regarding health insurance and the use of health care.

  • Received July 1, 1996.
  • Accepted October 25, 1996.
| Table of Contents
Advertisement